Back to results
US 8,940,897 B2Granted
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
AssigneeCubist Pharmaceuticals, Inc.
InventorsYu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III
Life of this patent
Estimating the term…
Abstract
β-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D β-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
Claims5
A compound of the formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.